Invention Grant
- Patent Title: Use of hyaluronidase for the prevention or treatment of arterial hypertension or cardiac insufficiency
-
Application No.: US16147222Application Date: 2018-09-28
-
Publication No.: US11000575B2Publication Date: 2021-05-11
- Inventor: Dieter Cullmann , Gunther Burgard
- Applicant: Pantarhin Pharma LLC
- Applicant Address: US FL Naples
- Assignee: Pantarhin Pharma LLC
- Current Assignee: Pantarhin Pharma LLC
- Current Assignee Address: US FL Naples
- Agency: Bozicevic, Field & Francis LLP
- Agent Paula A. Borden
- Priority: EP08017979 20081014
- Main IPC: A61K38/47
- IPC: A61K38/47 ; A61K38/55 ; A61K45/06 ; A61P9/12
Abstract:
The present invention relates to the use of hyaluronidase for the prevention and/or treatment of cardiac insufficiency. In addition, the present invention provides a composition and a combined preparation each comprising hyaluronidase and at least one further antihypertensive, and a method of prevention and/or treating cardiac insufficiency in a patient in need thereof, wherein the patient is administered a therapeutically effective amount of hyaluronidase.
Public/Granted literature
- US20190091302A1 USE OF HYALURONIDASE FOR THE PREVENTION OR TREATMENT OF ARTERIAL HYPERTENSION OR CARDIAC INSUFFICIENCY Public/Granted day:2019-03-28
Information query
IPC分类:
